Sakai, Y.; Miyawaki, S.; Teranishi, Y.; Okano, A.; Ohara, K.; Hongo, H.; Ishigami, D.; Shimada, D.; Mitsui, J.; Nakatomi, H.;
et al. NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas. Cancers 2022, 14, 3183.
https://doi.org/10.3390/cancers14133183
AMA Style
Sakai Y, Miyawaki S, Teranishi Y, Okano A, Ohara K, Hongo H, Ishigami D, Shimada D, Mitsui J, Nakatomi H,
et al. NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas. Cancers. 2022; 14(13):3183.
https://doi.org/10.3390/cancers14133183
Chicago/Turabian Style
Sakai, Yu, Satoru Miyawaki, Yu Teranishi, Atsushi Okano, Kenta Ohara, Hiroki Hongo, Daiichiro Ishigami, Daisuke Shimada, Jun Mitsui, Hirofumi Nakatomi,
and et al. 2022. "NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas" Cancers 14, no. 13: 3183.
https://doi.org/10.3390/cancers14133183
APA Style
Sakai, Y., Miyawaki, S., Teranishi, Y., Okano, A., Ohara, K., Hongo, H., Ishigami, D., Shimada, D., Mitsui, J., Nakatomi, H., & Saito, N.
(2022). NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas. Cancers, 14(13), 3183.
https://doi.org/10.3390/cancers14133183